Inflammatory biomarkers in Alzheimer's disease plasma

Angharad R. Morgan, Samuel Touchard, Claire Leckey, Caroline O'Hagan, Alejo J. Nevado-Holgado, Frederik Barkhof, Lars Bertram, Olivier Blin, Isabelle Bos, Valerija Dobricic, Sebastiaan Engelborghs, Giovanni Frisoni, Lutz Froelich, Silvey Gabel, Peter Johannsen, Petronella Kettunen, Iwona Koszewska, Cristina Legido-Quigley, Alberto Lleo, Pablo Martinez-LagePatrizia Mecocci, Karen Meersmans, Jose Luis Molinuevo, Gwendoline Peyratout, Julius Popp, Jill Richardson, Isabel Sala, Philip Scheltens, Johannes Streffer, Hikka Soininen, Mikel Tainta-Cuezva, Charlotte Teunissen, Magda Tsolaki, Rik Vandenberghe, Pieter Jelle Visser, Stephanie Vos, Lars-Olof Wahlund, Anders Wallin, Sarah Westwood, Henrik Zetterberg, Simon Lovestone, B. Paul Morgan*, Edward T. Bullmore, Junaid Bhatti, Samuel J. Chamberlain, Marta M. Correia, Anna L. Crofts, Amber Dickinson, Andrew C. Foster, Manfred G. Kitzbichler, NIMA–Wellcome Trust Consortium for Neuroimmunology of Mood Disorders and Alzheimer's Disease

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

49 Citations (Web of Science)
Original languageEnglish
Pages (from-to)776-787
Number of pages12
JournalAlzheimer's & Dementia
Volume15
Issue number6
DOIs
Publication statusPublished - Jun 2019

Keywords

  • Alzheimer's disease
  • Biomarker
  • Plasma
  • Inflammation
  • Complement
  • MILD COGNITIVE IMPAIRMENT
  • NONSTEROIDAL ANTIINFLAMMATORY DRUGS
  • GENOME-WIDE ASSOCIATION
  • IMMUNE-SYSTEM
  • CEREBROSPINAL-FLUID
  • IDENTIFIES VARIANTS
  • FACTOR-H
  • COMPLEMENT
  • SERUM
  • RISK

Cite this